Dr Reddy's Laboratories Assets & Liabilities Overview 2006-2018 | RDY

Current and historical assets & liabilities overview for Dr Reddy's Laboratories (RDY) from 2006 to 2018.
Dr Reddy's Laboratories Annual Assets & Liabilities Overview
(Millions of US $)
Dr Reddy's Laboratories Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.852B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $64.939B 11.14
Teva Pharmaceutical Industries (TEVA) Israel $24.771B 6.92
Mylan (MYL) United Kingdom $20.102B 8.55
Bausch Health Cos (BHC) Canada $8.712B 6.49
Supernus Pharmaceuticals (SUPN) United States $2.553B 27.32
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.466B 4.19
Akorn (AKRX) United States $1.658B 0.00
Assembly Biosciences (ASMB) United States $0.919B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.887B 127.87
Homology Medicines (FIXX) United States $0.808B 0.00
CymaBay Therapeutics (CBAY) United States $0.673B 0.00
Voyager Therapeutics (VYGR) United States $0.591B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.521B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.483B 0.00
Corium (CORI) United States $0.341B 0.00
Teligent (TLGT) United States $0.205B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.149B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Aevi Genomic Medicine (GNMX) United States $0.075B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.069B 0.00
Evoke Pharma (EVOK) United States $0.054B 0.00
Versartis (VSAR) United States $0.051B 0.00
Acasti Pharma (ACST) Canada $0.022B 0.00
Agile Therapeutics (AGRX) United States $0.012B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.011B 0.00